Phase 2 Osprey, Apteryx studies of QLS-111 meet all endpoints
Patients with primary open-angle glaucoma or ocular hypertension who received QLS-111 experienced lower IOP in two phase 2 trials, according to a press release from Qlaris Bio.
Related Articles
CGM may lead to lower health care costs for pregnant women with type 1 diabetes
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for women with type 1 diabetes, according to…
Kathryn Colby from NYU Langone gives insight into AI Optics Sentinel Camera
The device recently received 510(k) clearance from the US Food and Drug Administration.
‘Call to action’: Head and neck cancer trials in US becoming less diverse
Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past…
Sleep apnea severity impacts all-cause mortality rates, odds in veterans
Veterans with apnea-hypopnea index scores implying no sleep apnea or severe sleep apnea had higher all-cause mortality rates vs. those with mild/moderate sleep apnea, according…
Zenocutuzumab exhibits efficacy in NRG 1 fusion-positive cancers
Zenocutuzumab exhibited efficacy among patients with NRG1 fusion-positive cancers, according to phase 2 data published in The New England Journal of Medicine.Nearly one-third of the…
SGLT2 inhibitor plus calorie restriction improves diabetes remission rate
Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie…
Extreme heat may trigger thousands of hospitalizations in adults with Alzheimer’s
Older adults with Alzheimer’s disease and related dementias faced a greater risk for hospitalization after being continuously exposed to extreme heat, results from a cohort…
OCTA Derived Retinal Capillary Perfusion Measures in the Framingham Heart Study
To report baseline demographic associations and novel inter-eye correlations of retinal perfusion in the Framingham Heart Study (FHS).
How to contribute more dollars to tax-sheltered Roth accounts
For high-income earners, including physicians, getting funds directly into a Roth IRA or other after-tax accounts can be a complex challenge.
Healio seeks nominees for Disruptive Innovators in oncology/hematology
Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.Individuals who have changed the face of the specialty and pushed the status…